Genesis Swaps Software Rights for Stake in Real Time Genomics | GenomeWeb

NEW YORK (GenomeWeb News) — Genesis Research and Development will trade its rights to royalties on the sale of a genomics data querying software package for a stake in start-up bioinformatics company Real Time Genomics.

Auckland, New Zealand-based Genesis said today that it is converting the royalty rights to NetValue's SLIM Search software, which is based on Genesis' Cartesian technology, in exchange for a 10 percent stake in the Real Time Genomics. Genesis' interest will be held by New Zealand holding company Gene Value.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.